Intervention Protocol

Pharmacotherapy for trichotillomania

  1. Lara Hoppe1,*,
  2. Jonathan C Ipser2,
  3. Naomi Fineberg3,
  4. Samuel Chamberlain4,
  5. Dan J Stein1

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 21 JAN 2009

DOI: 10.1002/14651858.CD007662

Database Title

Additional Information

How to Cite

Hoppe L, Ipser JC, Fineberg N, Chamberlain S, Stein DJ. Pharmacotherapy for trichotillomania (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD007662. DOI: 10.1002/14651858.CD007662.

Author Information

  1. 1

    University of Cape Town, Department of Psychiatry and Mental Health, Cape Town, Western Cape, South Africa

  2. 2

    University of Stellenbosch, MRC Research Unit for Anxiety and Stress Disorders, Tygerberg, Western Cape, South Africa

  3. 3

    Queen Elizabeth II Hospital, National Obsessive Compulsive Disorders Treatment Service, Welwyn Garden City, Hertfordshire, UK

  4. 4

    University of Cambridge, Department of Psychiatry, Cambridge, UK

*Lara Hoppe, Department of Psychiatry and Mental Health, University of Cape Town, E36A Groote Schuur Hospital, Anzio Road, Observatory, Cape Town, Western Cape, 7925, South Africa. larahoppe@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Full (178K)
 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

1) To provide an estimate from RCTs of the efficacy of medication in reducing trichotillomania symptoms.

2) To compare particular classes of medication in terms of efficacy and tolerability in treating trichotillomania.

3) To identify which factors (clinical, methodological) predict response to medication.

View Full Article (HTML) Full (178K)